Figure 1.
Visualization of the standardized differences between neostigmine-reversed and sugammadex-reversed groups before and after inverse probability of treatment propensity score weighting. (Negligible difference is 0.05.)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.